Janux Therapeutics Inc Earnings

Janux Therapeutics Inc’s revenue fell -100% since last year same period to $0Mn in the Q2 2025. On a quarterly growth basis, Janux Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.

Janux Therapeutics Inc’s net profit fell -468.18% since last year same period to $-33.86Mn in the Q2 2025. On a quarterly growth basis, Janux Therapeutics Inc has generated -44.03% fall in its net profits since last 3-months.

Janux Therapeutics Inc’s net profit margin fell -Inf% since last year same period to -Inf% in the Q2 2025. On a quarterly growth basis, Janux Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.

Janux Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.62 - a -35.32% fall from last quarter’s estimates.

Janux Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.62.

Janux Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Janux Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.